Amarin Pharma sued the FDA on May 7 and declared it had the constitutional right to discuss off-label use of drugs with doctors, the New York Times reports.
Attorneys said this was the first time they can remember a pharmaceutical manufacturer filing a pre-emptive lawsuit against the FDA over a free-speech issue.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.